866-997-4948(US-Canada Toll Free)

Global Biologics Outsourcing Market: Insights, Trends & Forecast (2019-2023)

Published By :

Koncept Analytics

Published Date : Oct 2019

Category :

Pharmaceutical

No. of Pages : 105 Pages

The global biologics outsourcing market is estimated to reach US$26.4 billion in 2023, growing at a CAGR of 16.77% for the period spanning from 2019 to 2023. The factors such as increasing aging population, higher healthcare spending, rising incidences of chronic conditions, increasing R&D spending on biologics drugs and growing focus on biologics are expected to drive the market. However, growth of the industry will be challenged by high capital requirement, high technical requirement, regulatory issues and ability to capture customers from established competitors. A few notable trends include new drug development and increasing demand for antibody conjugates.

The global biologics outsourcing market is broadly segmented into two types which are instruments and kits & reagents. The use of antibodies for treating various chronic diseases such as asthma and diabetes is increasing investment in research activities which has stimulated the demand for biologics outsourcing market globally.

The fastest growing regional market is China owing to the Chinese government which has issued many regulations and policies to support the development of the biologics outsourcing market in China. Marketing Authorization Holder or MAH, Pilot Program for drug approval process allows biologics applicants with products that are manufactured in China to outsource the manufacturing process to third party biologics outsourcing service providers. The U.S. and Asia are highly established premium markets that contribute to significant shares in the global market.

Scope of the report:

  • The report provides a comprehensive analysis of the global biologics outsourcing market, segmented into two types which are instruments and kits & reagents.
  • The major regional markets have been analyzed, with the coverage of China.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Lonza Group, Wuxi Biologics, Boehringer Inhgelheim, Catalent Inc., Abzena and Thermo Fisher) are also presented in detail.

Key Target Audience:

  • Pharmaceutical Biotech Manufacturers
  • Individual Researchers
  • CROs/CDMOs/CMOs
  • Academic Institutes
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Content

1. Market Overview
1.1 Pharmaceutical Industry
1.2 Biologics
1.3 Manufacturing Process of Biologics
1.4 Medical Uses for Biologics
1.5 Products of Biologics
1.6 Biologics Outsourcing

2. Global Pharmaceutical Market
2.1 Global Pharmaceutical Market by Value
2.2 Global Pharmaceutical Market Forecast by Value
2.3 Global Pharmaceutical Market by Segment
2.3.1 Global Small Molecule Market by Value
2.3.2 Global Small Molecule Forecast Market by Value
2.3.3 Global Generics Market by Value
2.3.4 Global Generics Market Forecast by Value
2.3.5 Global OTC Market by Value
2.3.6 Global OTC Market Forecast by Value
2.3.7 Global Biosimilar Market by Value
2.3.8 Global Biosimilar Market Forecast by Value

3. Global Biologics Market
3.1 Global Biologics Market by Value
3.2 Global Biologics Market Forecast by Value
3.3 Global Biologics Market by Segment
3.3.1 Global mAb Market by Value
3.3.2 Global mAb Market Forecast by Value
3.4 Global Biologics Market by Region
3.5 Global Biologics Market Growth by Region

4. Global Biologics Outsourcing Market
4.1 Global Biologics Outsourcing Market by Value
4.2 Global Biologics Outsourcing Market Forecast by Value
4.3 Global Biologics Outsourcing Market by Type
4.3.1 Global Biologics Outsourcing Instrument Market by Value
4.3.2 Global Biologics Outsourcing Kits & Reagents Market Forecast by Value
4.4 Global Biologics Outsourcing Market Growth by Region

5. China Biologics/Biologics Outsourcing Market
5.1 China Biologics Market by Value
5.2 China Biologics Market Forecast by Value
5.3 China Biologics Market by Segment
5.3.1 China mAb Market by Value
5.3.2 China mAb Market Forecast by Value
5.4 China Biologics Outsourcing Market by Value
5.5 China Biologics Outsourcing Market Forecast by Value

6. Market Dynamics
6.1 Growth Drivers
6.1.1 Rising Ageing Population
6.1.2 Rising Incidences of Chronic Conditions
6.1.3 Escalating Healthcare Spending
6.1.4 Accelerating Economy
6.1.5 Growing Focus on Biologics
6.2 Key Trends & Developments
6.2.1 Increasing Spending on Biologics Drugs
6.2.2 New Drug Development
6.2.3 Increasing Demand for Antibody Conjugates
6.3 Challenges
6.3.1 High Capital Requirement
6.3.2 High Technical Requirement
6.3.3 Stringent Regulations
6.3.4 Ability to Capture Customers from Established Competitors

7. Competitive Landscape
7.1 Global Market
7.1.1 Revenue and Market Cap Comparison
7.1.2 Wuxi Biologics’ Share in Global Biologics Outsourcing Market
7.1.3 Global Biologics Outsourcing Market Share by Company
7.2 China
7.2.1 China Biologics Outsourcing Market Share by Company

8. Company Profiles
8.1 Lonza Group AG
8.1.1 Business Overview
8.1.2 Financial Overview
8.1.3 Business Strategies
8.2 Wuxi Biologics
8.2.1 Business Overview
8.2.2 Financial Overview
8.2.3 Business Strategies
8.3 Boehringer Ingelheim
8.3.1 Business Overview
8.3.2 Financial Overview
8.3.3 Business Strategies
8.4 Catalent Inc.
8.4.1 Business Overview
8.4.2 Financial Overview
8.4.3 Business Strategies
8.5 Abzena Limited
8.5.1 Business Overview
8.5.2 Financial Overview
8.5.3 Business Strategies
8.6 Thermo Fisher
8.6.1 Business Overview
8.6.2 Financial Overview
8.6.3 Business Strategies

List of Table

Key Players - Revenue & Market Cap Comparison (2018)
Catalent Inc. Segments and Their Offerings & Services (2018)

List of Chart

Segmentation of Pharmaceutical Industry
Biologics Value Chain
Manufacturing Process of Biologics
Products/Segments of Biologics
Global Pharmaceutical Market by Value (2014-2018)
Global Pharmaceutical Market Forecast by Value (2019-2023)
Global Pharmaceutical Market by Segment (2018)
Global Small Molecule Market by Value (2014-2018)
Global Small Molecule Forecast Market by Value (2019-2023)
Global Generics Market by Value (2014-2018)
Global Generics Market Forecast by Value (2019-2023)
Global OTC Market by Value (2014-2018)
Global OTC Market Forecast by Value (2019-2023)
Global Biosimilar Market by Value (2014-2018)
Global Biosimilar Market Forecast by Value (2019-2023)
Global Biologics Market by Value (2014-2018)
Global Biologics Market Forecast by Value (2019-2023)
Global Biologics Market by Segment (2018)
Global mAb Market by Value (2014-2018)
Global mAb Market Forecast by Value (2019-2023)
Global Biologics Market by Region (2018)
Global Biologics Market Growth by Region (2018-2023)
Global Biologics Outsourcing Market by Value (2014-2018)
Global Biologics Outsourcing Market Forecast by Value (2019-2023)
Global Biologics Outsourcing Market by Type (2018)
Global Biologics Outsourcing Instrument Market by Value (2018-2023)
Global Biologics Outsourcing Kits & Reagents Market Forecast by Value (2018-2023)
Global Biologics Outsourcing Market Growth by Region (2018-2023)
China Biologics Market by Value (2014-2018)
China Biologics Market Forecast by Value (2019-2023)
China mAb Market by Value (2014-2018)
China mAb Market Forecast by Value (2019-2023)
China Biologics Outsourcing Market by Value (2014-2018)
China Biologics Outsourcing Market Forecast by Value (2019-2023)
Global Population Above 65 Years (2014-2018)
The U.S. Prevalence of Chronic Diseases (2010-2030)
Global Healthcare Spending Per Capita (2014-2018)
Global GDP Per Capita (2014-2018)
Global Spending on Biologics Drugs (2014-2018)
Drug Discovery Market (2016/2025)
Wuxi Biologics’ Share in Global Biologics Outsourcing Market (2018-2023)
Global Biologics Outsourcing Market Share by Company (2018)
China Biologics Outsourcing Market Share by Company (2018)
Lonza Group Sales by Segments (2018)
Lonza Group Sales by Geographic Regions (2018)
Lonza Group Sales and Profit (2014-2018)
Wuxi Biologics Revenue by Region (2018)
Wuxi Biologics Revenue and Net Profit (2014-2018)
Boehringer Ingelheim Sales by Product Category (2018)
Boehringer Ingelheim Sales by Region (2018)
Boehringer Ingelheim Net Sales and Net Income (2014-2018)
Catalent Inc. Revenue by Segment (2018)
Catalent Inc. Revenue by Region (2018)
Catalent Inc. Net Revenue and Net Earnings (2014-2018)
Abzena Revenue by Segment (2018)
Abzena Revenue by Region (2018)
Abzena Revenue and Loss (2015-2018)
Thermo Fisher Revenue by Segment (2018)
Thermo Fisher Revenue by Region (2018)
Thermo Fisher Revenue and Net Income (2014-2018)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *